Geriatric Rheumatology and Arthritis

A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities have also led to the growth in the market. The global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025 to become worth US$ 52.96 bn by 2025 from US$41.88 bn in 2016. Nearly 20% of aged people who suffer a hip fracture die within a year. One out of every two women over 50 will have an osteoporosis-related fracture in their lifetime, with risk of fracture increasing with age. The global rheumatology therapeutics market is projected to be driven by the increasing geriatric population in developed countries. Also according to world arthritis day, more than 120 million people in European Union are affected by some of the forms of arthritis. The growing geriatric population in developed countries is likely to be key driving factor for global rheumatology therapeutics market. Geriatric Rheumatology is the branch of prescription that studies rheumatologic disarranges in matured. It is likewise called Gerontorheumatology. The geriatric rheumatology clinic provides evaluation and management services to patients with various musculoskeletal and soft tissue disorders. Geriatric Rheumatology fortifies the conflict that the present information perceive a knowledge gap and a need to readdress the characteristic chronicles and best treatment of rheumatic contamination in a demographic get together for which discharged experience and clinical test information are lacking. Gerontorheumatology concurs with the particular qualities of onset, course and cure of rheumatic diseases in patients of refined age. The essential conclusion of provocative rheumatic contamination after the age of 60 is prevented by the recurrence of non-particular general disease side effects. Arthritis is a disease causing painful inflammation and stiffness of the joints. Rheumatism or rheumatic disorder refers to an acute or chronic illness which is characterized by inflammation and reduced function of connecting or supporting structures such as the joints, tendons, ligaments, bones, and muscles. More updates can be found at Elderly Care Conferences.

  • Osteoarthritis
  • Autoimmune Arthritis
  • Infectious Arthritis
  • Psoriatic Arthritis 
  • Gout
  • Osteoporosis

Related Conference of Geriatric Rheumatology and Arthritis

June 21-22, 2024

52nd Global Nursing & Healthcare Conference

Rome, Italy
August 08-09, 2024

20th World Congress on Healthcare & Technologies

London, UK
September 09-10, 2024

3rd Global Summit on Physiology and Metabolism of Thyroid

Paris, France
September 18-19, 2024

29th International Conference on Skincare and Cosmetology

Amsterdam, Netherlands
September 19-20, 2024

20th Global Biomarkers and Clinical Research Summit

Paris, France
September 24-25, 2024

5th Global Summit on Public Health

Paris, France
November 11-12, 2024

9th Global Summit on Midwifery and Womens Health

Dubai, UAE
November 25-26, 2024

10th World Holistic Nursing Conference

Bali, Indonesia
November 25-26, 2024

4th International conference on Healthcare Summit

Bali, Indonesia
November 28-29, 2024

World Vaccine Meet 2024

Bali, Indonesia
July 24-25, 2025

36th European Heart and Heart Failure Congress

Paris, France

Geriatric Rheumatology and Arthritis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in